Bloomage BioTechnology Corporation Limited (SHA:688363)

Market Cap	16.07B -38.6%
Revenue (ttm)	3.69B -23.4%
Net Income	224.00M +319.8%
EPS	0.47 +325.1%
Shares Out	478.36M
PE Ratio	71.62
Forward PE	41.37
Dividend	0.19 (0.57%)
Ex-Dividend Date	Jul 13, 2026

Volume	2,423,080
Open	33.60
Previous Close	33.30
Day's Range	33.31 - 34.22
52-Week Range	32.92 - 56.03
Beta	0.45
Analysts	Hold
Price Target	35.70 (+6.25%)
Earnings Date	Oct 30, 2026

About SHA:688363

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers beauty and care products under brand Hymagic-VCHA VC Hylauronic Acid; Biomeet-MarineDNA; Bioyouth-SPG Schizophyllan Gel; Hymagic-GluHA; Bloomsurfact EncapCare RP; Bloomsurfact Sodium Surfactin; Hybloom Minitrue; Bioyouth-EGT Pure Ultrapure Ergothioneine; miniHA HA-Oligo degraded by hyaluronidase; microHA Super Active Hyaluronic Acid; Hymagic-AcHA Sodium Acetylated Hyaluronate; Hymagic-4D 4D Hyaluronic Acid; Hybloom Zinc Hyalurona...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2000
• Employees: 3,656
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688363

Financial Performance

In 2025, SHA:688363's revenue was 4.20 billion, a decrease of -21.82% compared to the previous year's 5.37 billion. Earnings were 292.06 million, an increase of 67.59%.

Analyst Summary

According to 8 analysts, the average rating for 688363 stock is "Hold." The 12-month stock price target is ¥35.70, which is an increase of 6.25% from the latest price.

Price Target

¥35.70

(6.25% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 16, 2026

Data Sources Report a data error